Healthcare & Medical Investment Corporation
Overview of the 23rd Term Financial Results (Executive Summary)
Public disclosure of the 23rd term results (for the year ending July 2026). Operating revenue was 2,659 million yen, net income for the period 1,015 million yen. Dividend per share: 3,174 yen. Unrealized gains: 13.05 billion yen, utilization rate maintained at 100%. Capital raised via a public offering expanded asset size, signaling a strategy to balance external and internal growth.
Key Figures
- Operating revenue: 2,659 million yen（YoY +25 million yen）
- Net income for the period: 1,015 million yen（YoY △41 million yen）
- Dividend per share: 3,174 yen（YoY △112 yen）
AI要約
Section Heading
The Financial Results section discloses the 23rd term's financial performance, dividend policy, and unrealized gains. Actuals include operating revenue of 2,659 million yen and net income of 1,015 million yen. The dividend per share is 3,174 yen, with a slight increase/decrease versus the forecast. Unrealized gains amount to 13.05 billion yen, with a 100% occupancy rate. The section also presents external growth through public fundraising and internal growth initiatives.
Section 2 Heading
Detailed growth strategy balancing external and internal growth. External growth through pipeline utilization and strengthening warehousing capabilities, with asset size expansion via the August 2026 public offering. Internal growth aims to stabilize dividends through contract revisions, rent negotiations, and diversification of asset types. Financial strategy emphasizes interest rate and LTV management, and strengthened cash management.
Revenue Trend
Operating Profit Trend
Dividend per Share Trend
NAV per Share Trend
Healthcare & Medical Investment Corporation
Company overview · Stock price · Financial data · All IR
